查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區肌肉減少症治療市場預測至 2030 年 - 區域分析 - 按治療類型和配銷通路
市場調查報告書
商品編碼
1562380

亞太地區肌肉減少症治療市場預測至 2030 年 - 區域分析 - 按治療類型和配銷通路

Asia Pacific Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 78 Pages | 訂單完成後即時交付

價格

2022年亞太肌減少症治療市值為6.9685億美元，預計2030年將達到11.6404億美元；預計2022年至2030年複合年成長率為6.6%。

臨床試驗階段的產品推動亞太肌少症治療市場

肌少症治療市場的一些主要參與者越來越關注治療肌少症的藥物開發。目前正在開發新的肌少症治療方法並進行臨床試驗。下面提到了其中一些產品：

  • 表 1. 臨床開發中的肌少症藥物

公司名稱 介入條件 臨床試驗階段

含 AN777 的雅培營養醫療食品

口服營養配方奶粉培養不良

肌少症第 3 階段

Nutricia Research 膳食補充劑：Bolus ONS A

膳食補充劑：Bolus ONS B

膳食補充劑：Bolus ONS C

膳食補充劑：ONS D 肌少症推注第 1 階段

諾華製藥藥物：Bimagrumab Sarcopenia PHASE2

麥克馬斯特大學行為學：逐步減少肌少症第 1 階段

Metabolic Technologies Inc. 膳食補充劑：安慰劑

藥物：HMB 加維生素 D

行為：非運動

行為：運動肌肉少症第 1 階段

Merck Sharp & Dohme LLC 藥物：比較劑 MK-077

藥物：對照安慰劑肌肉少症 PHASE2

膳食補充劑：Immunocal

膳食補充品：酪蛋白老化與肌少症第 2 階段

楊麗君組合產品：為期3個月的肌少症強化介入第4階段

再生元製藥藥物：REGN1033 (SAR391786)

藥物：安慰劑肌肉少症 PHASE2

資料來源：公司網站和 Insight Partners 分析

因此，處於不同臨床開發階段的藥物管道的不斷延伸為肌肉減少症治療市場的成長提供了重大機會。

亞太地區肌少症治療市場概況

亞太地區肌少症治療市場分為中國、印度、日本、韓國、澳洲和亞太其他地區。預計亞太地區在預測期內將成為全球市場中複合年成長率最快的地區。亞洲是世界上人口最多的大陸，人口迅速老化，肌少症相關問題在一些亞洲國家變得越來越普遍。亞洲人的生活方式和飲食習慣與西方世界的人截然不同。在亞洲，老年個體中肌少症在男性中更為常見（盛行率 9.6-22.1%）比女性更常見（盛行率 7.7-21.8%）。亞洲肌肉減少症工作小組 (AWGS) 旨在促進亞洲肌肉減少症研究。

亞太地區肌少症治療市場收入及 2030 年預測（百萬美元）

亞太地區肌少症治療市場區隔

亞太地區肌少症治療市場按治療類型、配銷通路和國家分類。

根據治療類型，亞太地區肌少症治療市場分為維生素 D 和鈣補充劑、蛋白質補充劑、維生素 B12 補充劑等。 2022 年，維生素 D 和鈣補充劑領域佔據亞太地區肌肉減少症治療市場佔有率最大。

在配銷通路方面，亞太肌肉減少症治療市場分為藥局、零售通路、線上通路等。 2022 年，藥局領域佔據亞太地區肌肉減少症治療市佔率最大。

依國家/地區分類，亞太地區肌少症治療市場分為中國、印度、日本、澳洲、韓國和亞太其他地區。 2022年，中國在亞太肌少症治療市場佔有率中佔據主導地位。

雅培實驗室、拜耳公司、Metagenics LLC、雀巢健康科學公司、諾華公司、輝瑞公司、賽諾菲公司、安麗公司和葛蘭素史克公司是亞太肌少症治療市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區肌少症治療市場 - 主要產業動態

  • 亞太地區肌少症治療市場 - 主要產業動態
  • 市場促進因素
    • 老年人口激增
    • 成人營養不良和維生素缺乏症增加
  • 主要市場限制：
    • 無法直接干預
  • 主要市場機會：
    • 處於臨床試驗階段的產品
  • 未來趨勢：
    • 人們對肌少症的認知不斷提高
  • 促進因素和限制的影響：

第 5 章：肌少症治療市場 - 亞太市場分析

  • 亞太地區肌少症治療市場收入，2020 - 2030
  • 亞太地區肌少症治療市場預測與分析

第 6 章：亞太地區肌肉減少症治療市場分析 - 依治療類型

  • 維生素 D 和鈣補充劑
  • 蛋白質補充劑
  • 維生素 B12 補充劑
  • 其他

第 7 章：亞太地區肌少症治療市場分析 - 按配銷通路

  • 藥局
  • 零售通路
  • 線上通路
  • 其他

第 8 章：亞太地區肌少症治療市場 - 國家分析

  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太地區其他地區

第 9 章：肌少症治療市場-產業格局

  • 概述
  • 肌少症治療市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 10 章：公司簡介

  • Abbott Laboratories
  • Bayer AG
  • Metagenics LLC
  • Nestle Health Science SA
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Amway Corp
  • GSK Plc

第 11 章：附錄

Product Code: BMIRE00030384

The Asia Pacific sarcopenia treatment market was valued at US$ 696.85 million in 2022 and is expected to reach US$ 1,164.04 million by 2030; it is estimated to register a CAGR of 6.6% from 2022 to 2030.

Products in Clinical Trial Phases Drive Asia Pacific Sarcopenia Treatment Market

A few major players operating in the sarcopenia treatment market are increasingly focusing on drug development to treat sarcopenia. Novel sarcopenia treatments are currently being developed and tested in clinical trials. A few of these products are mentioned below:

  • Table 1. Sarcopenia Drug Under Clinical Development

Company Name Interventions Conditions Clinical Trial Stage

Abbott Nutrition Medical Food with AN777

Oral Nutritional Formula Malnutrition

Sarcopenia PHASE3

Nutricia Research Dietary Supplement: Bolus ONS A

Dietary Supplement: Bolus ONS B

Dietary Supplement: Bolus ONS C

Dietary Supplement: Bolus ONS D Sarcopenia PHASE1

Novartis Pharmaceuticals Drug: Bimagrumab Sarcopenia PHASE2

McMaster University Behavioural: Step Reduction Sarcopenia PHASE1

Metabolic Technologies Inc. Dietary Supplement: Placebo

Drug: HMB Plus Vitamin D

Behavioural: Non-Exercise

Behavioural: Exercise Sarcopenia PHASE1

Merck Sharp & Dohme LLC Drug: Comparator MK-077

Drug: Comparator Placebo Sarcopenia PHASE2

Immunotec Inc. Dietary Supplement: Immunocal

Dietary Supplement: Casein Aging and Sarcopenia PHASE2

Lijun Yang Combination Product: 3-Month Intensive Intervention Sarcopenia PHASE4

Regeneron Pharmaceuticals Drug: REGN1033 (SAR391786)

Drug: Placebo Sarcopenia PHASE2

Source: Company Websites and The Insight Partners Analysis

Therefore, the extending pipeline of drugs that are in different stages of clinical development presents significant opportunities for the sarcopenia treatment market growth.

Asia Pacific Sarcopenia Treatment Market Overview

The Asia Pacific sarcopenia treatment market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific is expected to register the fastest CAGR in the global market during the forecast period. Asia is the world's most populated continent with a rapidly aging population, and sarcopenia-related issues are becoming more prevalent in several Asian countries. Asians led extremely different lifestyles and follow different dietary habits than people from the Western world. In Asia, sarcopenia in older individuals is more common in males (prevalence 9.6-22.1%) than females (prevalence 7.7-21.8%). Asian Working Group for Sarcopenia (AWGS) aims to promote sarcopenia research in Asia.

Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Sarcopenia Treatment Market Segmentation

The Asia Pacific sarcopenia treatment market is categorized into treatment type, distribution channel, and country.

Based on treatment type, the Asia Pacific sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Asia Pacific sarcopenia treatment market share in 2022.

In terms of distribution channel, the Asia Pacific sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Asia Pacific sarcopenia treatment market share in 2022.

By country, the Asia Pacific sarcopenia treatment market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific sarcopenia treatment market share in 2022.

Abbott Laboratories, Bayer AG, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp, and GSK Plc are some of the leading companies operating in the Asia Pacific sarcopenia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics

  • 4.1 Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Upsurge in Geriatric Population
    • 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
  • 4.3 Key Market Restraints:
    • 4.3.1 Unavailability of Direct Interventions
  • 4.4 Key Market Opportunities:
    • 4.4.1 Products in Clinical Trial Phases
  • 4.5 Future Trends:
    • 4.5.1 Rising Awareness About Sarcopenia
  • 4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • 5.2 Asia Pacific Sarcopenia Treatment Market Forecast and Analysis

6. Asia Pacific Sarcopenia Treatment Market Analysis - By Treatment Type

  • 6.1 Vitamin D and Calcium Supplement
    • 6.1.1 Overview
    • 6.1.2 Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Protein Supplement
    • 6.2.1 Overview
    • 6.2.2 Protein Supplement : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Vitamin B12 Supplement
    • 6.3.1 Overview
    • 6.3.2 Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Sarcopenia Treatment Market Analysis - By Distribution Channel

  • 7.1 Pharmacies
    • 7.1.1 Overview
    • 7.1.2 Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Retail Channels
    • 7.2.1 Overview
    • 7.2.2 Retail Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Online Channels
    • 7.3.1 Overview
    • 7.3.2 Online Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Sarcopenia Treatment Market - Country Analysis

  • 8.1 Asia Pacific
    • 8.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.7 Rest of Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.7.1 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.7.2 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Sarcopenia Treatment Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Bayer AG
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Metagenics LLC
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Nestle Health Science SA
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Novartis AG
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Pfizer Inc
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Sanofi SA
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Amway Corp
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 GSK Plc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Sarcopenia Treatment Market Segmentation
  • Table 2. Sarcopenia Drug Under Clinical Development
  • Table 3. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Table 4. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
  • Table 5. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
  • Table 6. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 7. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 8. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 9. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 10. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 11. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 12. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 13. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 14. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 15. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 16. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 17. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 18. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
  • Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
  • Table 21. Glossary of Terms, Sarcopenia Treatment Market

List Of Figures

  • Figure 1. Asia Pacific Sarcopenia Treatment Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Asia Pacific Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
  • Figure 5. Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Protein Supplement : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Asia Pacific Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
  • Figure 10. Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Retail Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Online Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Asia Pacific Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
  • Figure 15. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 16. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 17. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 18. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 19. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 20. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 21. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 22. Growth Strategies in the Sarcopenia Treatment Market